The Venture Codex Logo

The Venture Codex

Overview

Transformational medicines through 3D deep learning and drug discovery.

Total Raised

$130 M

Rounds

3

Links

Verticals

Artificial Intelligence (AI)
Biotechnology
Life Science

Investment History

  1. Series B

    Sep 2025

    $80M

  2. Series A

    Jun 2022

    $50M

Team

Laksh Aithani

Co-Founder, CEO, and Board Member

David Baker

Scientific Co-Founder

Beverley Carr

CBO

Nicholas Edmunds

Chief Development Officer and Head of Pre-Clinical Development